Dispensing investigational drugs: Regulatory issues and the role of the investigational drug service

American Journal of Health-System Pharmacy

Volumn 61, Issue 18, 2004, Pages 1882-1884

  Shehab, Nadine ^a   Tamer, Helen ^b,c  

^a Department of Pharmacy Services ^*

^b Investigational Drug Service   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ACCREDITATION; DRUG CONTROL; DRUG DISTRIBUTION; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; DRUG RESEARCH; DRUG SCREENING; DRUG STORAGE; DRUG SYNTHESIS; FOOD AND DRUG ADMINISTRATION; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; STANDARD;

EID: 8344232470     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.18.1882     Document Type: Short Survey

References (6)

1. Food and Drug Administration. International conference on harmonization: good clinical practice consolidated guidelines. Fed Regist. 1997; 62:25692-709.
2. Medication management. Sec. 1. In: Comprehensive accreditation manual for hospitals: the official handbook. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2004: MM1-20.
3. Guidelines on clinical drug research. In: Deffenbaugh JH, ed. Best practices for health-system pharmacy, position and guidance documents of ASHP, 2001-2002. Bethesda, MD: American Society of Health-System Pharmacists; 2002:294-300.
4. Rockwell KA, Marnocha RS. Audit tool for investigational drugs dispensed in clinics. Presented at ASHP Annual Meeting, Reno, NV; 1994 Jun.
5. Truelove KE, Ferolie ER, Ossing MM. Pharmacist auditing of investigational new drugs used in studies not dispensed by pharmacy. Presented at ASHP Annual Meeting, Philadelphia, PA; 1995 Jun.
6. Petrich JM, Suttles CC, Shermock KM. The impact of a quality control program within an investigational drug service. Presented at ASHP Midyear Clinical Meeting, Atlanta, GA; 2002 Dec.